Boehringer Ingelheim's Journey to More Effective Key Account Management
This page is a thin video-led marketing piece rather than a written case study. Its only substantive text is a caption stating 'Boehringer Ingelheim leverages Link Key Accounts to drive efficiencies and effectiveness when identifying key decision makers,' plus basic firmographic details (large biopharma, headquartered in Ingelheim am Rhein, Germany) and the featured solution, Veeva Link Key Accounts. There is no written narrative about the challenge, implementation, or measurable outcomes on the page itself — that content is locked inside an embedded video.
Veeva Systems is the dominant CRM and content platform in pharma commercial, regulatory, clinical and quality operations, now shipping AI agents directly inside those same production systems.
This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.
Published by Veeva Systems on its own site — read the original case study on veeva.com ↗
Related use cases
- 01Transforming Content Operations for 2x Faster Time to Market
- 02Astellas: Breaking Access Barriers with Veeva Compliant Chat
- 03How Pacira Generated Deep Website Insights to Get Patients on Therapy Faster
- 04Reaching Underserved Communities with Smarter Targeting
- 05Building Agile Territory Strategies to Scale Pre-Commercial Field Teams
- 06How Alfasigma Unified Regulatory Data and Processes for Cross-Functional Alignment